Cargando…

Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination

BACKGROUND: Myocarditis following coronavirus disease 2019 (COVID-19) mRNA vaccines (Pfizer-BioNTech and Moderna) has been increasingly reported. Incidence rates in the general population are lacking, with pericarditis rather than myocarditis diagnostic codes being used to estimate background rates....

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez, Yalile, Levy, Emily R, Joshi, Avni Y, Virk, Abinash, Rodriguez-Porcel, Martin, Johnson, Matthew, Roellinger, Daniel, Vanichkachorn, Greg, Charles Huskins, W, Swift, Melanie D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767838/ https://www.ncbi.nlm.nih.gov/pubmed/34734240 http://dx.doi.org/10.1093/cid/ciab926

Ejemplares similares

Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
por: Virk, Abinash, et al.
Publicado: (2023)

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
por: Tande, Aaron J, et al.
Publicado: (2021)

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
por: Straus, Walter, et al.
Publicado: (2022)

Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
por: Kim, Paul S., et al.
Publicado: (2022)

Diagnostic Approach for Classic Compared With Localized Whipple Disease
por: Crews, Nicholas R, et al.
Publicado: (2018)

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
por: Mwimanzi, Francis, et al.
Publicado: (2023)

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Magnus, Maria C, et al.
Publicado: (2022)

Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database
por: Yoon, Jin Gu, et al.
Publicado: (2023)

Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

End-of-Therapy Echocardiography May Not Be Needed in All in Patients With Endocarditis
por: Virk, Abinash, et al.
Publicado: (2020)

In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study
por: Richardson, Safiya, et al.
Publicado: (2021)

Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
por: Andrejko, Kristin L, et al.
Publicado: (2021)

Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis
por: Spinelli, Matthew A, et al.
Publicado: (2022)

Opioid Injection-Associated Bacterial Infections in England, 2002–2021: A Time Series Analysis of Seasonal Variation and the Impact of Coronavirus Disease 2019
por: Lewer, Dan, et al.
Publicado: (2023)

Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More
por: Joshi, Seema, et al.
Publicado: (2021)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
por: Swift, Melanie D, et al.
Publicado: (2021)

Surge in Incidence and Coronavirus Disease 2019 Hospital Risk of Death, United States, September 2020 to March 2021
por: Patel, Bela, et al.
Publicado: (2022)

Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
por: Hakre, Shilpa, et al.
Publicado: (2022)

Incidence and Prevalence of Coronavirus Disease 2019 Within a Healthcare Worker Cohort During the First Year of the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic( )
por: Doernberg, Sarah B, et al.
Publicado: (2022)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

The Collapse of Infectious Disease Diagnoses Commonly Due to Communicable Respiratory Pathogens During the Coronavirus Disease 2019 Pandemic: A Time Series and Hierarchical Clustering Analysis
por: Zhang, Ali, et al.
Publicado: (2022)

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019( )
por: Castanha, Priscila M S, et al.
Publicado: (2022)

Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies
por: Sherman, Amy C, et al.
Publicado: (2022)

A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination
por: Bengel, Christopher Paul, et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID-19) mRNA vaccine and the risk of myocarditis: An increasing concern
por: Shaikh, Omer Ahmed, et al.
Publicado: (2021)

Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model
por: Li, Can, et al.
Publicado: (2021)

Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine and Myocarditis
por: Singh, Balraj, et al.
Publicado: (2021)

Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China
por: Cheng, Biheng, et al.
Publicado: (2020)

Spread of Coronavirus 2019 From Wuhan to Rural Villages in the Hubei Province
por: You, Maolin, et al.
Publicado: (2020)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

The Clinical and Radiological Manifestations in Coronavirus Disease 2019 With Negative Nucleic Acid Results
por: Lang, Guanjing, et al.
Publicado: (2020)

Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center
por: Yoke, Leah H, et al.
Publicado: (2021)

Serologic and Cytokine Signatures in Children With Multisystem Inflammatory Syndrome and Coronavirus Disease 2019
por: Lapp, Stacey A, et al.
Publicado: (2022)

Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia
por: DiNubile, Mark J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5sgo0a3nh4kgt15ckek8l706oq